Spoken Alpha
SMMT
Summit Therapeutics Inc.
Overview
Summit Therapeutics develops ivonescimab, a bispecific antibody combining immunotherapy and anti-angiogenesis effects, for treating non-small cell lung cancer and colorectal cancer.
Summit Therapeutics Inc is a Healthcare company operating in Biotechnology with a $11.09B market cap.
Most recent earnings call: Q4 FY25 on Feb 24, 2026.
11 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q4 FY2025Earnings2026-02-2424 Q&A exchanges
- Q3 FY2025Earnings2025-10-2019 Q&A exchanges
- Q1 FY2025Earnings2025-05-0227 Q&A exchanges
- Q4 FY2024Earnings2025-02-2431 Q&A exchanges
- Q3 FY2024Earnings2024-10-3011 Q&A exchanges
- Q1 FY2024Earnings2024-05-015 Q&A exchanges
- Q4 FY2023Earnings2024-02-205 Q&A exchanges
- Q3 FY2023Earnings2023-11-073 Q&A exchanges
- Q2 FY2023Earnings2023-08-092 Q&A exchanges
- Q1 FY2023Earnings2023-05-111 Q&A exchange
- Q4 FY2022Earnings2023-03-101 Q&A exchange
History
Earnings history
Reported quarters with consensus, surprise, and 1-day reaction context.
Track Record
SampleSpoken Alpha tracks SMMT's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 8/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 3 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2025 | $1.15 | $1.15 | -0.1% | -2.6% | -4.1% |
| Q4 FY2025 | $1.33 | $1.37 | -2.6% | -0.1% | -1.5% |
| Q3 FY2025 | $1.18 | $1.30 | -9.5% | +4.1% | +2.7% |
| Q2 FY2025 | $1.16 | $1.18 | -1.6% | -2.1% | -0.9% |
| Q1 FY2024 | $1.36 | $1.39 | -2.2% | -4.2% | -7.0% |
| Q4 FY2024 | $1.12 | $1.21 | -7.6% | +1.5% | +3.5% |
| Q3 FY2024 | $1.38 | $1.32 | +4.7% | -2.4% | -2.3% |
| Q2 FY2024 | $1.45 | $1.49 | -2.8% | +2.1% | +3.3% |
| Q1 FY2023 | $1.34 | $1.38 | -3.1% | +2.6% | +2.1% |
| Q4 FY2023 | $1.53 | $1.55 | -1.1% | -2.3% | -0.6% |
Guidance change history
Sample- Q1 FY2025Maintained2025-04-15
- Q4 FY2025Maintained2025-13-15
- Q3 FY2025Lowered2025-10-15
- Q2 FY2025Maintained2025-07-15
- Q1 FY2024Maintained2024-04-15
- Q4 FY2024Lowered2024-13-15
- Q3 FY2024Raised2024-10-15
- Q2 FY2024Maintained2024-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Mahkam ZanganehCEO1 yr 9 mo5 callsCurrentSample
CEO since 2024 • 3/4 beats (75%) • last guidance raise Q3 FY2025
- Robert W DugganCEO1 yr 9 mo11 callsCurrentSample
CEO since 2024 • 3/4 beats (75%) • last guidance raise Q2 FY2025
- Manmeet Singh SoniCFO1 yr 9 mono recorded callsCurrentSample
CFO since 2024 • 2/4 beats (50%) • last call held guidance Q3 FY2025
- Bhaskar AnandChief Accounting Officer1 yr 5 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 1/2 beats (50%) • last call held guidance Q3 FY2025
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SMMT.
$ curl https://api.spokenalpha.com/v1/companies/SMMTFAQ
Frequently asked about SMMT
Where can I find Summit Therapeutics Inc.'s (SMMT) earnings call transcripts?
Spoken Alpha indexes SMMT's earnings call transcripts at https://spokenalpha.com/companies/SMMT. Each call links to attributed speakers and parsed analyst Q&A.
When was Summit Therapeutics Inc.'s most recent earnings call?
Summit Therapeutics Inc. (SMMT) held its most recent earnings call on 2026-02-24, covering fiscal Q4 2025.
What sector is SMMT in?
Summit Therapeutics Inc. (SMMT) operates in the Healthcare sector (Biotechnology industry).